Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zoledronate In the Prevention of Paget's Disease: Long Term Extension

NCT03859895 is registered in ClinicalTrials.gov with University of Edinburgh as lead sponsor.

NCT NCT03859895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03859895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zoledronate In the Prevention of Paget's Disease: Long Term Extension
Lead sponsor
University of Edinburgh
Phase
Observational
Overall status
Enrolling by invitation
Start date
April 5, 2019
Completion date
May 31, 2027
Enrollment
287 (estimated)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

paget disease